MedicarePartD.guide

A non-government resource built from CMS public data

denosumab biosimilars on Wellcare Classic (S4802-076)

Jubbonti, Ospomyv and others

Covered, with prior authorization on some forms.

Tier 4 (non-preferred drug). Quantity limit of 1 per 180 days.

$83.96
Patient pays / month, after deductible
$289.53
Patient pays / month, before the $615.00 deductible
$251.89
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

STOBOCLO 60 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $289.53 for a month. Other covered strengths are listed below.

Prior authRequired on 2 of 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
CONEXXENCE 60 mg/mL Injection4$85.731 per 180 days
BOMYNTRA 70 mg/mL Injection525%PA
BOMYNTRA 70 mg/mL Injection525%PA
STOBOCLO 60 mg/mL Injection4$83.961 per 180 days

Other Osteoporosis drugs on this plan

Verify with the plan before prescribing or filling. Member services: (888)550-5252. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s4802-076